Notch proteins participate in conserved pathways that regulate cell fate determination, cell differentiation, cell proliferation and cell death (1) (2) (3) (4) . Mammalian Notch receptors (Notch1-Notch4) are cell-surface type I transmembrane proteins that harbor a large extracellular domain involved in ligand binding and a cytoplasmic domain involved in signal transduction (5) (6) (7) . The Notch1 receptor is processed in the trans-Golgi network by proteases of the furin (S1 cleavage) during transport to the cell surface, where it is expressed in heterodimeric form (8) . At the cell surface, Notch can interact with ligands, Jagged and Delta. The transmembrane Cterminal fragment of Notch is generated via proteolytic cleavage (S2 cleavage), which subsequently cleaves the Notch fragment by gamma-secretase (S3 cleavage), an enzyme complex that contains presenilin (PS1), nicastrin (NCT), anterior pharynx defective (APH-1) and presenilin enhancer-2 (PEN-2). This process then results in the release of the Notch intracellular domain (Notch-IC) (9,10) (11-23). Notch1-IC translocates to the nucleus and interacts with various transcriptional activation complexes including CSL (CBF1/RBP-Jk, suppressor of hairless, Lag-1), coactivator protein MAML-1 (mastermind-like-1), and p300/CBP (CREB-binding protein), which possess histone acetyltransferase (HAT) activity, leading to transcriptional activation of downstream target genes such as those encoding Hes1, Hes5, Hes7, Hey1, Hey2, HeyL, and Cyclin D (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) . In the absence of Notch-IC, CSL recruits corepressor factors, including SKIP (Ski-interacting protein), SMRT (silencing mediator for retinoid and thyroid hormone receptors), N-CoR (nuclear receptor corepressor), and HDAC (histone deacetylases), resulting in the formation of a transcriptional repressor complex (6, 35, 36) .
The SMRT corepressor participates in the repression of target gene expression through a variety of transcription factors, including the nuclear hormone receptors and promyelocytic leukemia zinc finger protein (37) (38) (39) . The ability of SMRT to associate with these transcription factors and thereby to mediate repression is strongly inhibited by activation of tyrosine kinase signaling pathways, including pathways regulated by the epidermal growth factor receptor (40) . Recent studies have emphasized the role of ubiquitination in regulating SMRT stability. Phosphorylation of SMRT by MEKK-1, Cdk2 and Pin1 induces conformational changes and reduces its binding affinity for transcription factors that promote its degradation (41, 42) . Phosphorylation of SMRT by IKKalpha has important meaning for the derepression of NF-kB and Notch target genes (43) . Recent studies have emphasized the role of ubiquitination in regulating SMRT stability. The SMRT phosphorylationdependent ubiquitination and degradation is an important negative feedback regulation that specifically terminates SMRT activation.
Wnt5a is a member of the Wnt family of secreted growth factor, which are 38-45 kDa secreted cysteine-rich proteins with hydrophobic signal peptides (44) . Wnt5a is a highly conserved diffusible protein whose signal is transduced by Frizzled (Fz) receptors. In addition to Fzs, receptor tyrosine kinase-like orphan receptor 1/2 (Ror1/2), which is a single-pass transmembrane receptor with a tyrosine kinase domain, functions as a co-receptor (44, 45) . However, the effect of Fzs and Ror1/2 on Wnt5a signaling has not yet been examined. Wnt can be broadly divided into three signaling pathways: the canonical Wnt/β-catenin pathway, the non-canonical Wnt/Ca 2+ pathway, and the noncanonical Wnt/planar cell polarity (PCP) pathway (46, 47) . Wnt5a is non-canonical pathway member of the Wnt family. Wnt5a is expressed in various adult tissues and are involved in a wide range of cellular processes. Signal transduction events through β-catenin-independent non-canonical Wnt5a elicits intracellular release of Ca 2+ , thereby activating the Ca 2+ /Calmodulin dependent protein kinase II (CaMKII), mitogen-activated protein kinase (MAPK), protein kinase C (PKC), and calpain to regulate cellular functions including cell migration (48) (49) (50) (51) (52) (53) (54) . CaMKII is the key component in Wnt5a signaling and has been shown to regulate Wnt5a signaling. CaMKII is a multifunctional serine (Ser)/threonine (Thr) kinase that plays an important role in the regulation of cell growth, cytoskeletal organization, regulation of synaptic transmission, modulation of ion channel activity, learning and memory (55) (56) (57) (58) . CaMKII is important for prostate cancer cell survival and promotes their progression to an androgen-independent state (59) . Furthermore, a recent study has shown that Calcium/calmodulindependent kinase II regulates notch-1 signaling in prostate cancer cells (60) . Wnt5a is transcribed based on multiple mechanisms, such as NF-kB, Hedgehog, TGF-beta, and Notch signaling cascades (61). Wnt5a expression in the human cells was induced by coculture and was blocked by gammasecretase inhibition. Likewise, stimulation of Notch signaling by immobilized Jagged-1 promoted Wnt5a expression (62) . Wnt5a acts as an essential downstream mediator of Notch-CSL signaling, which is dependent on expression in the keratinocyte compartment of FoxN1, a gene that plays a key role in hair follicle regulatory function (63) . Despite these observations, the precise mechanisms underlying the relationship between the Notch1 and Wnt5a-CaMKII signaling pathways are still largely unknown.
In this study, we demonstrated that Wnt-5 induced CaMKII enhances the Notch1 signaling pathway through the downregulation of SMRT protein stability. CaMKII was shown to phosphorylate SMRT, which disrupts the SMRT-RBP-Jk transcription complex through SMRT protein degradation and polyubiquitination. In addition, the dissociation of SMRT from RBP-Jk provoked by CaMKII activates Hes1 and Hes5 transcriptional activity. The results of this study suggest that CaMKII is crucial for the regulation between Notch and Wnt signaling.
Eagle's medium (DMEM) supplemented with 10% FBS, 100 U/ml penicillin, and 100 μg/ml streptomycin. For plasmid DNA transfection, cells were plated at a density of 2 × 10 6 cells/100-mm dish, grown overnight, and transfected with the appropriate expression vectors in the presence of the indicated combinations of plasmid DNAs via the calcium phosphate and liposome method (64) .
Luciferase reporter assay -Human embryonic kidney 293 cells were co-transfected with 4XCSL-Luc (a 4-time repeating section of the RBP-Jk target sequence, CGTGGGAA, with the luciferase gene), Hes1-Luc, Hes5-Luc, mutating the RBP-Jk binding site of Hes5-Luc, and -galactosidase coupled with the indicated vector constructs. 48 hours after transfection, the cells were lysed in chemiluminescence lysis buffer (18.3% of 1 M K 2 HPO 4 , 1.7% of 1 M KH 2 PO 4 , 1mM phenylmethylsulfonyl fluoride (PMSF), and 1mM dithiothreitol) and luciferase activity was assayed using a luciferase assay kit (Promega). The activity of the luciferase reporter protein in the transfected cells was normalized to the -galactosidase activity in the same cells (65) . These results represent the means ± average deviation of three independent experiments. R.L.U means relative luciferase units. Protein accumulation assay-For the protein accumulation assay, the cells were seeded at a density of 50-60% confluence and incubated overnight. 48 hours after transfection, cells were treated with the proteasomal inhibitor MG-132 (Sigma-Aldrich). The MG-132 concentrations in the dosage assay were 0, 1 and 5 M and the treatment time was 6 hours. Protein levels were analyzed via immunoblotting (65) . Protein stability assay -For the protein stability assay, the cells were seeded at a density of 50-60% confluence and incubated overnight. 48 hours after transfection, the cells were treated with 0.1 mM cycloheximide for 0, 0.5, 1, 2, 4, or 6 hours to block the synthesis of new proteins. The cells were collected at each time point and the total lysates were then lysed in RIPA/ Laemmli buffer. Protein levels of endogenous Notch1 were determined by immunoblotting with the indicated antibody (65) . In vitro binding assay -The recombinant GST-SMRT proteins were expressed in Escherichia coli strain BL21, using the pGEX system as indicated (66) . The GST-SMRT proteins were then purified using glutathione-agarose beads (Sigma), in accordance with the manufacturer's instructions. Equal amounts of GST or GST-SMRT fusion proteins were incubated with the lysates of HEK293 cells, which had been transfected for 3 hours with combinations of expression vectors at 4°C, with rotation. After incubation, the beads were washed three times with ice-cold PBS, and boiled with 20 μl of Laemmli sample buffer. The precipitates were separated via SDS-PAGE, and the pull-down proteins were detected via immunoblotting with specific antibodies. Co-immunoprecipitation Assays -The cells were lysed in 1 ml of RIPA buffer for 30 minutes at 4°C. After 20 minutes of centrifugation at 12,000 × g, the supernatants were subjected to immunoprecipitation with the appropriate antibodies coupled to protein A-agarose beads. The resulting immunoprecipitates were then washed three times in phosphate-buffered saline (PBS, pH 7.4). Laemmli sample buffer was then added to the immunoprecipitated pellets. The pellets were heated for 5 minutes at 95°C and analyzed via SDS-PAGE. Western blotting was conducted with the indicated antibodies. Western blot analysis-The cultured cells were harvested and lysed in RIPA buffer (50mM TrisHCl (pH 7.5), 150mM NaCl, 1% Nonidet P-40, 0.5% Sodium deoxycholate, 0.1% SDS, 1mM PMSF, 1mM DTT, and 2g/ml leupeptin and aprotinin for 30 min. The cell lysates were subjected to 20 min of centrifugation at 12,000g and 4 °C. The resultant soluble fraction was then boiled in Laemmli buffer and subjected to SDS-PAGE. After gel electrophoresis, the separated proteins were transferred onto polyvinylidene difluoride (PVDF) membranes (Millipore) via electroblotting. The membranes were then blocked with Tris-buffered saline solution (pH 7.4) containing 0.1% Tween 20 and 5% nonfat milk. The blotted proteins were probed with the indicated antibodies. Antibody list -The blotted proteins were probed using anti-Myc antibody (9E10), anti-HA (12CA5) antibody, anti-Flag M2 (Sigma Chemical Co.), antiNotch1-IC (Cell Signaling), anti-RBP-Jk (Santa Cruz), anti-CaMKII (Santa Cruz), anti-SMRT (Santa Cruz), anti-Presenilin1 (D39D1) rabbit mAb, anti-Presenilin 2 (D30G3) rabbit mAb (Cell Signaling Technology) followed by incubation with anti-mouse horseradish peroxidaseconjugated secondary antibodies (Amersham Biosciences, Inc.). The blots were then developed using an enhanced chemiluminescence (ECL) system (Pierce). Site directed mutagenesis -The site-directed mutagenesis of cDNA encoding for SMRT was performed using a QuikChange kit (Stratagene), and the mutagenic primer was S1407A (5'-GGGGACCGGCCACCCgCTGTCTCCTCAGTGC AC-3') and S1434A (5'-GAGGACAGGCCCTCGgCCGCAGGTTCCACGC C-3') (mismatches with the SMRT cDNA template are indicated by lowercase letters). The mutations were verified by automatic DNA sequencing. Immunocomplex kinase assay -The cultured cells were harvested and lysed in buffer A, containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM phenylmethylsulfonyl fluoride (PMSF), 2 µg/ml of leupeptin, 2 µg/ml of aprotinin, 25 mM glycerophosphate, 0.1 mM sodium orthovanadate, 1 mM sodium fluoride, 1% NP-40, 0.5% deoxycholate, and 0.1% SDS for 30 min at 4 °C. The cell lysates were then subjected to centrifugation at 12,000 × g and 4 °C for 20 min. The soluble fraction was incubated for 3 h with the appropriate antibodies against the indicated protein kinase at 4 °C. The immunocomplexes were then coupled to protein Aagarose during an additional hour of incubation at 4 °C, after which they were pelleted via centrifugation. The immunopellets were rinsed three times with lysis buffer and then twice with 20 mM HEPES (pH 7.4). The immunocomplex kinase assays were conducted by incubating the immunopellets for 30 min at 30 C with 2 g of substrate protein in 20 l of reaction buffer that contained 0.2 mM sodium orthovanadate, 10 mM MgCl 2 , 2 Ci [ 32 P]ATP, 20 mM HEPES (pH 7.4). The phosphorylated substrates were separated by SDS-PAGE and quantified using a Fuji FLA7000 phosphoImager. The GST fusion proteins that were used as substrates were expressed in E. coli using pGEX-4T (Pharmacia) and purified using glutathione-Sepharose, as described previously (66, 67) . The protein concentrations were determined by the Bradford method (Shimadzu). Immunofluorescence staining -Assays were conducted as previously described with HEK293 cells plated at a density of 1x10 5 cells per well onto cover slips (Fisher). Cells were transfected with a total of 0.5 mg of the appropriate DNA per well using the Lipofectamine-plus reagent (Invitrogen). The transfected cells were fixed with 4% paraformaldehyde in phosphate-buffered saline (PBS), and then permeabilized with 0.1% Triton-X 100 in PBS. Cells were blocked in 1% BSA in PBS. Anti-HA or anti-Flag M2 antibodies (Sigma Chemical Co.) were employed as the primary antibodies at a dilution of 1:100, washed three times in PBS. Alexa Fluor 488 (Invitrogen) or Alexa-555 (Invitrogen) conjugated anti-mouse secondary antibody (1:100) was added, and then the DNA dye ToPro-3 was used for nuclear localization. The stained cells were evaluated for localization via confocal microscopy (Leica TCS SPE). Each image consisted of a single Z section at the same cellular level. The final images were obtained using a confocal microscopy and analyzed with LAS AF software (Leica) and at least 300 cells were counted for each experimental condition. Scale bars represent 25 m as indicated (68) . Preparation of cytosolic and nuclear fractions -The cells were rinsed with ice-cold PBS, and harvested via 5 minutes of centrifugation at 3,000 rpm and 4°C. The dispersed cells were then homogenized with buffer A (10 mM HEPES, pH 7.9, 10 mM KCl, 0.5 mM EDTA, 1 mM DTT, and 0.5 mM PMSF). After 15 minutes on ice, 10% NP-40 was added and vortexed vigorously for 10 seconds. The resultant supernatant was then used as a cytosolic fraction, via 1-2 minutes of centrifugation at 13,000 rpm and 4°C. The pellet was then homogenized with buffer B (20 mM HEPES, pH 7.9, 0.4 M NaCl, 1 mM EDTA, 1 mM DTT, and 1 mM PMSF). After 10 minutes of vigorous vortexing, the homogenates were centrifuged for 10 minutes at 13,000 rpm at 4°C. The resultant supernatants were then used as nuclear fractions. Two fractions were quantified using the Bradford method and 20 g of the each fraction were analyzed by SDS-PAGE (66) .
RESULTS

Wnt5a enhances the transcriptional activity of
Notch1 target genes through CaMKII -To determine whether Wnt5a is involved in regulating the transcriptional activation of Notch1 target genes, a reporter assay was performed with HEK293 cells using luciferase reporter genes. In this study, three types of luciferase reporter genes under the control of the Hes1 promoter, the Hes5 promoter, and the artificial four time repeat of RBP-Jk binding sequence were evaluated. We investigated the effect of Wnt5a on Notch1-IC transcriptional activity. HEK293 cells were transfected with 4XCSL-Luc and either the Notch1-IC or an empty vector. As expected, Notch1-IC mediated transcription activity increased in these samples ( Figure. 1A ). The Notch1-IC induced 4XCSL luciferase reporter activity was enhanced by co-transfection with Wnt5a in a dose-dependent manner ( Figure. 1A ). The bHLH proteins Hes1 and Hes5, both of which contain multiple CSL binding DNA sequences on their promoters, were identified as essential targets of Notch in epithelial cells. Therefore, we have confirmed the effects of Wnt5a on the Notch1 signaling pathway, using the Hes1, Hes5 reporter and RMHes5 reporter systems, respectively. RMHes5-Luc was constructed by mutating the RBP-J binding site (-79 to -72: tgtggaa) of Hes5-Luc to tgtgctga (69) . Expression of Notch1-IC was determined to significantly induce activation of the Hes1 and Hes5 reporter systems ( Figure. 1B-C). Wnt5a enhanced Notch1-IC induced natural Hes1 and Hes5 promoter transcriptional activity in a dose dependent manner, but not RMHes5 activity ( Figure. 1B-C). Moreover, The Notch1-IC induced 4XCSL luciferase reporter activity was enhanced by purified Wnt5a in a dose-dependent manner ( Figure. 1D ). Based on these results, it was assumed that Wnt5a can activate the expression of the Notch1 target genes.
In order to delineate the possible role of CaMKII in the regulation of Notch1 signaling by Wnt5a in intact cells, we assessed the effects of the CaMKII inhibitor and CaMKII dominant negative on Notch signaling. We determined that the KN-93 or CaMKII dominant negative was able to block the effects of Wnt5a on Notch1-IC-induced transcriptional activity ( Figure. . These data demonstrate that CaMKII could activate the Notch1 reporter activity despite the absence of Notch1-IC generation, suggesting that CaMKII, at least in part, could regulate Notch1 target gene expression in a Notch1-IC independent manner. However, the absolute value of three reporter systems was higher in PS1/2 +/+ MEF cells than PS1/2 -/-MEF cells, suggesting that CaMKII could modulate Notch1 activity through a Notch1-IC dependent and independent manner.
To investigate whether the transcriptional activation of endogenous Notch1 target genes by CaMKII occurs through a RBP-Jk dependent manner, we performed a transcription reporter assay using the dominant negative form of RBP-Jk (RBPJk-DN). In the luciferase reporter gene assay with PS1/2 -/-MEF cells, RBP-Jk-DN was transfected and the effect of this transfection on the transcriptional inhibition of Notch1-IC target genes was then assessed using 4XCSL-Luc. The transcriptional activity of endogenous Notch1-IC was activated by CaMKII but was inhibited by cotransfection with RBP-Jk-DN, suggesting that CaMKII activates Notch1 transcriptional activity through a RBP-Jk dependent mechanism (Figure. 3G). To investigate whether the kinase activity of CaMKII is necessary for the up-regulation of the transcriptional activity of Notch1 target genes, we used a dominant-negative, kinase deficient CaMKII mutant (CaMKII-K42M, called CaMKII-DN) to block the kinase activity of CaMKII. In the luciferase reporter gene assay with PS1/2 -/-MEF cells, CaMKII-DN was transfected instead of CaMKII, and the effect of this transfection on the transcriptional activation of endogenous Notch1-IC target genes was assessed using 4XCSL-Luc. The transcriptional activity of endogenous Notch1-IC was enhanced by CaMKII but was not enhanced by transfection with the dominant negative CaMKII (Figure. ). Thus, the upregulation of the Notch1-IC activity by CaMKII could be dependent on the intact kinase activity of CaMKII through RBP-Jk dependent and Notch1-IC independent mechanism. CaMKII modulates the binding of RBP-Jk to Notch1-IC or SMRT -To observe the effects of Wnt5a on the molecular interactions between Notch1-IC and RBP-Jk, co-immunoprecipitation was performed in HEK293 cells that had been cotransfected with Myc-tagged Notch1-IC, Flagtagged RBP-Jk, and Wnt5a. Immunoprecipitation was performed on cell lysates using an anti-Flag antibody, and immunoblotting was performed using the anti-Myc antibody. Notch1-IC and RBP-Jk were co-immunoprecipitated, but when they were cotransfected with Wnt5a, the band intensity corresponding to the interaction between Notch1-IC and RBP-Jk was enhanced ( Figure. 4A) . We evaluated the physical association between Notch1-IC and RBP-Jk by Wnt5a in immunocomplexes that were collected using anti-Myc antibody. These results confirmed that the interaction between Notch1-IC and RBP-Jk was enhanced in the presence of Wnt5a. In the presence of KN-93, the association between Notch1-IC and RBP-Jk by Wnt5a was reduced, suggesting that CaMKII kinase activity might play an important role in the Notch1-IC-RBP-Jk interaction ( Figure. 4B ). We next evaluated the effects of KN-93 on the association of endogenous Notch1-IC and RBP-Jk by Wnt5a in intact cells. In these experiments, HEK293 cells were transiently transfected with Wnt5a. 42 hours after transfection, cells were treated with exogenous KN-93 for 6 hours, and then the affinity between these two proteins was measured. Wnt5a facilitated the physical association between Notch1-IC and RBP-Jk and this binding was substantially suppressed by KN-93 treatment, suggesting that Wnt5a induced CaMKII activation plays a critical role in the endogenous Notch1-IC-RBP-Jk binding ( Figure. 4C) . In order to further assess whether CaMKII plays a positive role in Notch1-IC-RBP-Jk binding, co-immunoprecipitation was performed in HEK293 cells with co-transfection of Myc-tagged Notch1-IC, Flag-tagged RBP-Jk, HA-tagged CaMKII, and HA-tagged CaMKII-DN. In the presence of CaMKII, the interaction between Notch1-IC and RBP-Jk was higher than in the absence of CaMKII transfection and had no effect on CaMKII-DN ( Figure. 4D) .
To evaluate the effects of Wnt5a on the molecular interactions between SMRT and RBP-Jk, co-immunoprecipitation was performed in HEK293 cells that had been co-transfected with Flag-tagged SMRT, Myc-tagged RBP-Jk, and Wnt5a. SMRT and RBP-Jk were co-immunoprecipitated, but when they were co-transfected with Wnt5a, the band corresponding to the SMRT-RBP-Jk complex disappeared ( Figure. 4E ). We also examined the effects of KN-93 on the association of endogenous RBP-Jk and SMRT by Wnt5a in intact cells. In these experiments, HEK293 cells were transiently transfected with Wnt5a. 42 hours after transfection, the cells were treated with exogenous KN-93 for 6 hours, and then affinity between these two proteins was measured. Wnt5a inhibited the physical association between RBP-Jk and SMRT and this binding was substantially rescued by KN-93 treatment, suggesting that Wnt5a induced CaMKII activation plays a critical role in the endogenous RBP-Jk-SMRT binding ( Figure. 4F) . To confirm the role of CaMKII in the regulation of RBP-Jk-SMRT transcription repressor complex, coimmunoprecipitation was performed in HEK293 cells that had been co-transfected with Flag-tagged SMRT, Myc-tagged RBP-Jk, HA-tagged CaMKII and HA-tagged CaMKII-DN. SMRT and RBP-Jk were co-immunoprecipitated, but when they were co-transfected with CaMKII, the band corresponding to the SMRT-RBP-Jk complex disappeared ( Figure. 4G) . Furthermore, the dominant-negative mutant of CaMKII (CaMKII-DN) had no effect on the binding between RBP-Jk and SMRT, suggesting that the kinase activity of CaMKII is essential for the physical binding between RBP-Jk and SMRT ( Figure. 4G ). Interestingly, in the cell lysate immunoblot, the level of endogenous and ectopic expressed SMRT proteins, but not Notch1-IC and RBP-Jk, was significantly down-regulated upon coexpression with Wnt5a or CaMKII ( Figure. 4E-G) , which shows that CaMKII may regulate the steady state level of SMRT protein. These results indicate that Wnt5a mediated CaMKII activation facilitates not only the formation of the Notch1-IC-RBP-Jk transcription activator complex but also the dissociation of the RBP-Jk-SMRT transcription repressor complex due to the down regulation of SMRT protein level. CaMKII down-regulates the steady state level of SMRT protein -Next, HEK293 cells were subjected to western blot analysis to determine whether CaMKII plays a role in the regulation of the SMRT protein level. Cells were co-transfected with Flagtagged SMRT, HA-tagged CaMKII and HA-tagged CaMKII-DN. We found that the SMRT protein level was reduced upon co-transfection of CaMKII but was not reduced upon co-transfection of CaMKII-DN ( Figure. 5A ). This result showed that the kinase activity of CaMKII is essential for the regulation of the SMRT protein level. In an effort to determine whether the degradation of SMRT proteins by CaMKII is mediated by the proteasome pathway, the proteasome inhibitor MG132 was administered to SMRT and CaMKII-expressing cells. The cells were then subjected to 6 hours of proteasome inhibitor treatment, and the SMRT protein level was measured via an immunoblot assay. Our studies demonstrated that the SMRT protein level was reduced in the presence of CaMKII, but was significantly restored by treatment with MG132 ( Figure. 5B) . In an effort to evaluate the possible role of CaMKII in the regulation of SMRT protein stability, we transfected HEK293 cells with Flagtagged SMRT, HA-tagged CaMKII and HA-tagged CaMKII-DN, and the quantity of remaining SMRT was analyzed after various periods of cycloheximide treatment. We determined the protein stability of SMRT in HEK293 cells by cycloheximide treatment with or without CaMKII. After cycloheximide treatment, the SMRT protein level gradually decreased, where approximately half of the protein was degraded after 1. ). HEK293 cells were subjected to western blot analysis to determine whether purified Wnt5a plays a role in the regulation of the endogenous SMRT protein level. The expression level SMRT protein was reduced by purified Wnt5a in a dose-dependent manner ( Figure. 5D ). We then attempted to characterize the involvement of CaMKII activity in the poly-ubiquitination of SMRT. Cells were cotransfected with Flag-tagged SMRT, GFP-tagged CaMKII and HA-tagged Ub, and were then subjected to ubiquitination analysis. Immunoblot analysis of the Flag immunoprecipitates from the transfected cells with an anti-HA antibody showed that CaMKII facilitated the ubiquitination of SMRT and KN93 prevented the ubiquitination of SMRT ( Figure. 5E ). These results showed that the kinase activity of CaMKII is essential for regulating the SMRT protein level. Physical interaction of CaMKII with SMRT in intact cells -In order to delineate more precisely the manner in which CaMKII facilitates Notch1-IC transcriptional activity, we conducted a series of in vitro binding and coimmunoprecipitation experiments. In the in vitro binding experiments, purified GST or GST-SMRT proteins were immobilized onto GSH-agarose. HA-CaMKII expressing cell lysates were incubated with either GST or GST-SMRT, both of which were immobilized onto GSH-agarose. The interaction between GST-SMRT and CaMKII was detected on bead complexes (Figure. 6A ). However, no interaction was observed between GST and CaMKII ( Figure. 6A ). We next attempted to determine whether CaMKII could physically associate with SMRT. Here, HEK293 cells were cotransfected with vectors encoding Flag-tagged wild-type SMRT and HA-tagged CaMKII and were then subjected to coimmunoprecipitation analysis after treatment with MG132 (5M) for 6 hours. Immunoblot analysis of HA immunoprecipitates from cells transfected with an anti-Flag antibody revealed that Flag-SMRT physically associated with HA-CaMKII in the cells (Figure. 6B ). We also examined whether endogenous CaMKII and SMRT could interact in intact cells. Using HEK293 cells, immunoblot analysis of the SMRT immunoprecipitates using an anti-SMRT antibody indicated that endogenous CaMKII and SMRT were physically associated ( Figure. 6C) . SMRT has the positions of two silencing domains (SD1 and SD2) and of two nuclear receptor interaction domains (RID1 and RID2) in its structure. We investigated which of these domains might be involved in the interaction between SMRT and CaMKII. We used purified GST and GST-SMRT deletion mutant proteins: SMRT-SD1, SMRT-SD2, SMRT-RID1 and SMRT-RID2. In the in vitro binding studies, purified GST and GST-SMRT deletion mutant proteins were immobilized on GSH agarose. Cell lysates expressing HA-CaMKII were incubated with either GST or with GST-SMRT deletion mutants immobilized on GSH-agarose. The interaction between GST-SMRT-RID1 and CaMKII was detected on bead complexes ( Figure. 6D ). In these experiments, we demonstrated that SMRT physically interacts with CaMKII via the RID1 domain.
The phosphorylation of SMRT by CaMKII is critical for degradation of SMRT protein -We next
conducted an in vitro kinase assay using CaMKII and purified GST-SMRT. The CaMKII immunocomplexes prepared from the HEK293 cells catalyzed the phosphorylation of purified recombinant GST-SMRT. Dominant negative CaMKII did not phosphorylate SMRT protein ( Figure. 7A ). Next, we conducted an in vitro kinase assay with HA-CaMKII and purified GST-SMRTdeletion mutants (GST-SMRT-SD1, GST-SMRT-SD2, GST-SMRT-RID1 and GST-SMRT-RID2). Serial deletion mutants of SMRT were employed in the CaMKII phosphorylation reaction in order to determine the phosphorylation site of SMRT.
CaMKII phosphorylated GST-SMRT-RID2 but did not phosphorylate the other three deletion mutants ( Figure. 7B ). These results demonstrated that the phosphorylation sites were located between residues 1291-1495 of SMRT. This region harbors two conserved sequence for CaMKII phosphorylation (R-X-X-S/T): Ser1407 and Ser1434. Furthermore, using site-directed mutagenesis, we determined that the replacement of Ser1407 of SMRT with alanine reduced the in vitro phosphorylation of the recombinant protein by the CaMKII immunoprecipitates ( Figure. 7C) . Moreover, we found that SMRT (S1407A) was resistant to CaMKII-induced degradation, which implies that the CaMKII-induced phosphorylation of SMRT is crucial for the degradation of the SMRT protein ( Figure. 7D ). We then used coimmunoprecipitation to examine the role of phosphorylation in the physical association between RBP-Jk and SMRT. In these experiments, HEK293 cells were cotransfected with vectors coding for Myc-tagged RBP-Jk, HAtagged CaMKII, Flag-tagged SMRT, and Flagtagged SMRT (S1407A) and were then subjected to coimmunoprecipitation analysis. Immunoblot analysis of the Flag immunoprecipitates from the cells transfected showed that CaMKII does not prevent the physical association between RBP-Jk and SMRT (S1407A) in cells (Fig. 7E) . Next, we examined the effect of CaMKII on the transcriptional repressive activity of SMRT and SMRT (S1407A) mutant in HEK293 cells. CaMKII was shown to activate the basal level of Notch1-induced transcriptional activity in the presence of wild type SMRT; however, CaMKII did not activate the basal level of Notch1-induced transcriptional activity in the presence of wild type SMRT(S1407A) (Figure. 7F) . Moreover, we attempted to determine whether CaMKII could modulate SMRT localization within cells. To determine the effect of CaMKII on SMRT localization, HEK293 cells were cotransfected with vectors coding for HA-tagged CaMKII, Flag-tagged SMRT, and Flag-tagged SMRT (S1407A) and were then subjected immunofluorescence staining after treated with MG132 (5M) for 6 hours.. As expected, SMRT was localized predominantly in the nucleus and CaMKII was distributed throughout the nucleus and cytoplasm (Fig. 7G, H) . As shown in Figure 7G and 7H, coexpression of CaMKII facilitated the translocation of SMRT from the nucleus to cytoplasm. We also found that CaMKII was localized predominantly in the cytoplasm in the presence of SMRT. Furthermore, CaMKII did not affect the subcellular localization of SMRT (S1407A). We found that SMRT (S1407A) was localized predominantly in the nucleus, suggesting that CaMKII mediated phosphorylation of SMRT was critical to the regulation of cellular localization of the SMRT protein. These data suggest that CaMKII-mediated phosphorylation of SMRT is an important step in CaMKII mediated activation of Notch1 signaling in intact cells.
DISCUSSION
Wnt and Notch signaling pathways belong to a highly conserved network that controls gene expression during development, adult tissue maintenance and disease (70) . Recent studies have implied that these pathways crosstalk in mammals (71, 72) . A recent study has suggested that CaMKII, a component of the non-canonical Wnt signaling pathway, regulates Notch1 signaling pathway (60) . However the mechanism of this regulation has not been clearly established. In this study, we demonstrated that Wnt5a induced CaMKII enhances Notch transcriptional activity. CaMKII physically interacts with SMRT through the RID1 domain and disrupts the SMRT-RBP-Jk transcription complex through degradation of SMRT. Dissociation of SMRT from RBP-Jk provoked by CaMKII activates Hes1 and Hes5 transcriptional activity. CaMKII can phosphorylate SMRT and activate the Notch1 signaling pathway. The kinase activity of CaMKII was required for up-regulation of the transcription activity of Notch1 target genes. To the best of our knowledge, this is the first demonstration of CaMKII-mediated positive regulation of Notch signaling through proteasomal degradation of SMRT.
Several recent studies have shown that ubiquitination mediated protein degradation plays a role in the regulation of Notch1 signaling through degradation of Notch1 ligands, Notch1 itself, and RBP-Jk (65, 66, (73) (74) (75) . This study provides the first evidence that the CAMKII is an endogenous positive regulator of the Notch signaling pathway through degradation of the SMRT corepressor. When CAMKII activity was enhanced by Wnt5a, the Notch1 transcriptional activity was significantly increased in HEK293 cells. This was examined in two different experiments: treating the cells with a CaMKII inhibitor, and expressing the dominantnegative mutant CaMKII. In both experiments, the basal Notch1-IC transcriptional activity was substantially suppressed. On the other hand, when CAMKII was overexpressed, the Notch1 transcriptional activity was markedly increased in a dose-dependent manner. Our findings provide unequivocal evidence that CAMKII is an endogenous signaling agent that up-regulates Notch1-IC transcriptional activity. Previous studies have suggested that CaMKII regulates Notch1 signaling in C4-2B cells. Inhibition of CaMKII activity by KN93 leads to a decrease in the steady state level of Notch1-IC protein and down-regulates the expression of Notch1 target gene Hes-1 and its promoter activity (60) . In contrast, the steady state level of Notch1-IC was not changed under these experimental conditions. The transcriptional activation of downstream target genes by Notch1-IC depends on the association of Notch1-IC and RBP-Jk within the nucleus (6). Wnt5a and CaMKII facilitate the interaction between Notch1-IC and RBP-Jk and this interaction was inhibited by a CaMKII inhibitor or dominant negative CaMKII in intact cells. After binding to DNA, RBP-Jk recruits a co-repressor complex that includes SMRT and HDAC1 to exert its inhibitory effect on transcription (6). We found that Wnt5a and CaMKII inhibit the interaction between Notch1-IC and RBP-Jk and this interaction was rescued using a CaMKII inhibitor or dominant negative CaMKII in intact cells. Based on these results, we propose that endogenous CaMKII, which was induced by Wnt5a, may facilitate Notch1 transcriptional activity due to the stable association between Notch1-IC and RBP-Jk and dissociation between RBP-Jk and SMRT corepressor. Surprisingly, in the cell lysate immunoblot, the SMRT protein level was down-regulated upon cotransfection of Wnt5a or CaMKII and the SMRT protein level was restored using a CaMKII inhibitor or dominant negative CaMKII. These results show that Wnt5a may regulate the level of the SMRT protein.
We also demonstrated that the RID1 domain of SMRT physically interacts with CaMKII and the kinase activity of CaMKII was shown to be essential for the regulation of the SMRT protein level. Recent studies have suggested that SMRT, a member of Notch co-repressor complex, is phosphorylated and degraded in a proteasomedependent manner (41) (42) (43) 76) . Degradation of SMRT is associated with the regulation of the Notch1 signaling pathway. In this study, we found that CaMKII stimulated the proteasomal degradation of ectopically expressed SMRT, and the reduction of SMRT levels by CaMKII was also observed through a proteasome-dependent mechanism. Our findings show that the kinase activity of CaMKII plays a crucial role in the proteasomal degradation of SMRT. Furthermore, the kinase activity of CaMKII was critical to the binding and inhibition of the Notch1 signaling pathway. Amino acids Arg-X-XSer/Thr motif were preferentially phosphorylated by CaMKII and SMRT contains several putative serine and threonine phosphorylation sites (77,78). We found that SMRT contains a conserved sequence for phosphorylation by CaMKII. CaMKII phosphorylated the SMRT protein and the phosphorylation sites were shown to be located between residues 1291-1495 of SMRT, a region that harbors two conserved serine residues: Ser1407 and Ser1434. Furthermore, we demonstrated that CaMKII-mediated SMRT phosphorylation on Ser1407 results in a decrease in the degradation of SMRT protein. CaMKII was also shown to positively regulate the transcriptional activation of the Notch1-IC target genes and the stability of SMRT protein by phosphorylation of SMRT at the Ser1407 residue. Thus, enhanced SMRT phosphorylation may be a possible mechanism for the CaMKII-mediated ubiquitination and proteasomal degradation of SMRT ( Figure. Previous reports have shown that MEKK1, Cdk2 and Pin1, CK2, and IKKalpha induced phosphorylation mediated SMRT translocation from the nucleus to the cytoplasm and proteasomedependent degradation (41) (42) (43) 76) . In this report, we also found that CaMKII mediates a similar phosphorylation event on SMRT corepressors at S1407 and thereby facilitates translocation from the nucleus to the cytoplasm. These results explain why CaMKII-induced phosphorylation of SMRT was required for proteasomal degradation and translocation from the nucleus to the cytoplasm.
In summary, Wnt5a induced CaMKII enhances Notch transcriptional activity. CaMKII physically interacts with SMRT and disrupts the SMRT-RBP-Jk transcription complex through degradation of SMRT protein. Dissociation of SMRT from RBP-Jk induced by CaMKII activates Hes1 and Hes5 transcriptional activity. Furthermore, CaMKII can phosphorylate SMRT and activate the Notch1 signaling pathway. The kinase activity of CaMKII was required for the up-regulation of the transcription activity of Notch1 target genes. The results of this study suggest that CaMKII plays a pivotal role in the signal cross-talk between Wnt5a and Notch signaling through downregulation of the SMRT corepressor protein. was used to visualize nuclei. For each experiment, at least 300 cells were examined, and the images shown here represent the typical staining pattern for a majority of the cells. The mean nuclear localization intensity per cell was analyzed by imaging cytometric analysis. White Scale bar, 25 m. (H) HEK293 cells were transfected with empty vector, 0.5 g of HA-CaMKII, 0.5 g of Flag-SMRT, and 0.5 g of Flag-SMRT (S1407A) as indicated. 48 hours after transfection, the cells were fractionated into cytosolic (Cyto), and nuclear (Nuc) fractions. Cell lysates were also immunoblotted with anti-Flag and anti-HA antibodies. LaminB and -actin were used as nuclear and cytoplasmic fraction marker. DN, Dominant Negative. IgG H , immunoglobulin heavy chain. IB, immunoblot. 
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